RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Aug 13, 2021

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

Jul 30, 2021

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Apr 18, 2021

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

SARS Vaccine and IBD Tweetorial Summary from December 1

Dec 5, 2020

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

Apr 21, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine As testing for SARS-CoV-2 is expanded and serologic antibody testing becomes available, we are faced with a number of different clinical scenarios. I have outlined the different situations...

Three waves of Illness from the COVID-19 Pandemic

Apr 1, 2020

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

HealthCentral features Dr. Rubin on COVID-19 and IBD

by dtrubin | April 3, 2020 | In the Press | 0 Comments

In light of the COVID-19 pandemic, Dr. Rubin has been active in informing IBD patients what we know, don't know, and what experts suggest. This HealthCentral article covers "What People With IBD Need to Know about COVID-19". Dr. Rubin says the general recommendation...

Dr. David T. Rubin Summarizes His Presentation from the Advances in Inflammatory Bowel Diseases Conference on Preparing for IBD Care in the Next Pandemic

by nmgarcia | December 13, 2021 | In the Press | 0 Comments

Click here for the full video of Dr. Rubin detailing his 8-point strategy for steps the gastroenterology community should take to prepare for another pandemic in the future to ensure the best outcomes for patients and conditions for professionals.

Hospital-stay duration after IBD surgery not linked to sleep, activity

by dtrubin | December 16, 2019 | biosensor, In the Press | 0 Comments

Second-year Pritzker medical student, Yangtian Yi, received Best Abstract in Surgery at AIBD 2019 for his abstract associating length of stay for IBD surgical patients with data collected from wearable devices. His oral presentation and abstract was reported on by...

Approach to Management and Interpretation of Testing Results in Patients with IBD, with Particular Attention to Restarting Therapy

by dtrubin | April 21, 2020 | Coronavirus, Rubin's Reflections | 0 Comments

Dr. David T. Rubin Discusses the Efficacy and Safety of JAK Inhibitors

by David Rubin | June 7, 2023 | In the Press | 0 Comments

Click here to read Conference Coverage on Dr. Rubin's talk at AIBD Virtual Regionals 2023, "JAK Inhibitors: Efficacy and Safety." He details the pivotal clinical trials that help us understand JAK-inhibitors, as well as real-world evidence of their success in patients.

Should You Scale Back on Your UC Treatment?

by zfine | May 28, 2025 | In the Press | 0 Comments

A provocative new paper proposes that less could be more for some people when it comes to drug therapy for IBD. https://www.healthcentral.com/news/ulcerative-colitis/should-you-scale-back-on-your-uc-treatment

Lee Matricaria’s Story

by David Rubin | February 12, 2021 | In the Press | 0 Comments

David T. Rubin Accepts the 2020 Sherman Prize

by David Rubin | February 1, 2022 | In the Press | 0 Comments

Watch David T. Rubin accept the 2020 Sherman Prize, which is awarded to IBD clinicians, surgeons, researchers and/or academics with extraordinary track records of achievement, making exceptional and pioneering contributions that transform IBD care.

Special Edition VGR: COVID-19 Vaccine Update

by David Rubin | April 2, 2021 | In the Press | 0 Comments

Click here to watch Dr. David Rubin and his colleagues explain the data behind the various vaccines, clinical recommendations, allergy and safety recommendation, and describe COVID-19 vaccine special issues in underrepresented minorities.

Dr. David T. Rubin on Transabdominal Ultrasound for IBD: Lessons from STARDUST Substudy on Ustekinumab

by David Rubin | January 19, 2024 | In the Press | 0 Comments

Intestinal ultrasound has become a useful tool in assessing disease progression and pathophysiology of inflammatory bowel disease (IBD). It’s an approach to visualizing the intestines using a transabdominal ultrasound probe to provide real-time information. But could...